ARTICLE | Company News
Catena, University of Virginia Patent Foundation deal
October 13, 2008 7:00 AM UTC
The university granted Catena an exclusive, worldwide license to IP covering VPC51299 and chemistries and methods related to GPCR antagonists that have antiangiogenic properties. VPC51299 is a lysoph...